Why combine and why neoadjuvant? Tumor immunological perspectives on chemoimmunotherapy in triple-negative breast cancer DOI Creative Commons
Kazuhiro Kakimi, Tomoharu Sugie

Breast Cancer, Journal Year: 2025, Volume and Issue: unknown

Published: May 6, 2025

Language: Английский

De-escalation of Adjuvant Therapy in Operatively Managed HPV Associated Oropharyngeal Carcinoma: Current Status and Future Directions DOI
J. Daniel, David M. Routman

Seminars in Radiation Oncology, Journal Year: 2025, Volume and Issue: 35(2), P. 166 - 172

Published: March 14, 2025

Language: Английский

Citations

0
Why combine and why neoadjuvant? Tumor immunological perspectives on chemoimmunotherapy in triple-negative breast cancer DOI Creative Commons
Kazuhiro Kakimi, Tomoharu Sugie

Breast Cancer, Journal Year: 2025, Volume and Issue: unknown

Published: May 6, 2025

Language: Английский

Citations

0